Specifically, the dysregulation of HDAC1 leads to the repression of tumor suppressor genes and promotion of oncogenic pathways, contributing to tumorigenesis, while HDAC3, a class I HDAC, is also implicated in HCC progression through the modulation of apoptosis and immune responses [22]. The gene discussed is HDAC1; the disease is hepatocellular carcinoma.